Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibodies to Escherichia coli K and O antigens in protection against acute pyelonephritis.

× No keyword cloud information.

10 in total

1. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Authors: Thomas A Russo; Janet M Beanan; Ruth Olson; Stacy A Genagon; Ulrike MacDonald; John J Cope; Bruce A Davidson; Brian Johnston; James R Johnson
Journal: Vaccine Date: 2007-02-05 Impact factor: 3.641

2. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.

Authors: Lionel Durant; Arnaud Metais; Coralie Soulama-Mouze; Jean-Marie Genevard; Xavier Nassif; Sonia Escaich
Journal: Infect Immun Date: 2006-12-04 Impact factor: 3.441

3. Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.

Authors: Varinder Kumar; N k Ganguly; Kusum Joshi; Rahul Mittal; Kusum Harjai; Sanjay Chhibber; Saroj Sharma
Journal: Med Microbiol Immunol Date: 2005-05-21 Impact factor: 3.402

10. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.

Authors: P O'Hanley; D Lark; S Falkow; G Schoolnik
Journal: J Clin Invest Date: 1985-02 Impact factor: 14.808

10 in total

Antibodies to Escherichia coli K and O antigens in protection against acute pyelonephritis.

1. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

2. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.

3. Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.

Review 4. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.

Review 5. Virulence factors in Escherichia coli urinary tract infection.

6. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.

7. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.

8. The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.

9. Escherichia coli K5 antigen in relation to various infections and in healthy individuals.

10. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.